Switch theme
Sign up to access all valuation multiples
Jacques Bogart SA is a France-based company engaged in the production and commercialization fragrances and cosmetics. The company's portfolio of brands includes Bogart and licenses for Ted Lapidus, Carven Chevignon, Lee Cooper and Naf Naf, among others.
1975
1.3K+
LTM Revenue n/a
LTM EBITDA n/a
$288M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Jacques Bogart has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Jacques Bogart achieved revenue of $315M and an EBITDA of $47.6M.
Jacques Bogart expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Jacques Bogart valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $315M | n/a | XXX | XXX | XXX |
| Gross Profit | $132M | $162M | XXX | XXX | XXX |
| Gross Margin | 42% | NaN% | XXX | XXX | XXX |
| EBITDA | $47.6M | n/a | XXX | XXX | XXX |
| EBITDA Margin | 15% | NaN% | XXX | XXX | XXX |
| Net Profit | $0.8M | -$11.2M | XXX | XXX | XXX |
| Net Margin | 0% | NaN% | XXX | XXX | XXX |
| Net Debt | n/a | $13.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Jacques Bogart's stock price is EUR 5 (or $6).
Jacques Bogart has current market cap of EUR 76.9M (or $82.6M), and EV of EUR 268M (or $288M).
See Jacques Bogart trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $288M | $82.6M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Jacques Bogart has market cap of $82.6M and EV of $288M.
Jacques Bogart's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Jacques Bogart's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Jacques Bogart and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $288M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpJacques Bogart's NTM/LTM revenue growth is n/a
Jacques Bogart's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Jacques Bogart's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Jacques Bogart's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Jacques Bogart and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 53% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Jacques Bogart acquired XXX companies to date.
Last acquisition by Jacques Bogart was XXXXXXXX, XXXXX XXXXX XXXXXX . Jacques Bogart acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Jacques Bogart founded? | Jacques Bogart was founded in 1975. |
| Where is Jacques Bogart headquartered? | Jacques Bogart is headquartered in France. |
| How many employees does Jacques Bogart have? | As of today, Jacques Bogart has 1.3K+ employees. |
| Who is the CEO of Jacques Bogart? | Jacques Bogart's CEO is Mr. David Konckier. |
| Is Jacques Bogart publicy listed? | Yes, Jacques Bogart is a public company listed on PAR. |
| What is the stock symbol of Jacques Bogart? | Jacques Bogart trades under JBOG ticker. |
| When did Jacques Bogart go public? | Jacques Bogart went public in 1989. |
| Who are competitors of Jacques Bogart? | Similar companies to Jacques Bogart include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Jacques Bogart? | Jacques Bogart's current market cap is $82.6M |
| Is Jacques Bogart profitable? | Yes, Jacques Bogart is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
